Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-07

Clinical Trial Update: Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From Turkey

View source ↗

Summary

This clinical trial update reports a retrospective cohort study from Turkey evaluating the use of dapagliflozin in patients with type 2 diabetes mellitus. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca Turkey | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED